Combination therapy with long-acting β-agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects

Peter Frith

doi:10.1136/ebm1050

Combination therapy with long-acting β-agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects

Peter Frith

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	78-79
Number of pages	2
Journal	Evidence-Based Medicine (English Edition)
Volume	15
Issue number	3
DOIs	https://doi.org/10.1136/ebm1050
Publication status	Published - Jun 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1136/ebm1050

Cite this

@article{1311c15bbbd740109b6b288a7d430d4d,

title = "Combination therapy with long-acting β-agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects",

author = "Peter Frith",

year = "2010",

month = jun,

doi = "10.1136/ebm1050",

language = "English",

volume = "15",

pages = "78--79",

journal = "Evidence-Based Medicine (English Edition)",

issn = "1356-5524",

publisher = "BMJ Publishing Group",

number = "3",

}

Combination therapy with long-acting β-agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects. / Frith, Peter.
In: Evidence-Based Medicine (English Edition), Vol. 15, No. 3, 06.2010, p. 78-79.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Combination therapy with long-acting β-agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects

AU - Frith, Peter

PY - 2010/6

Y1 - 2010/6

UR - https://www.scopus.com/pages/publications/77953805142

U2 - 10.1136/ebm1050

DO - 10.1136/ebm1050

M3 - Comment/debate

SN - 1356-5524

VL - 15

SP - 78

EP - 79

JO - Evidence-Based Medicine (English Edition)

JF - Evidence-Based Medicine (English Edition)

IS - 3

ER -

Combination therapy with long-acting β-agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects

UN SDGs

Access to Document

Other files and links

Cite this